The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment

J Thromb Haemost. 2006 Jun;4(6):1418-20. doi: 10.1111/j.1538-7836.2006.01962.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • ABO Blood-Group System* / genetics
  • Anticoagulants / adverse effects*
  • Case-Control Studies
  • Factor VIII / metabolism
  • Hemorrhage / etiology*
  • Humans
  • Risk Factors
  • Vitamin K / antagonists & inhibitors
  • Warfarin / adverse effects
  • von Willebrand Factor / metabolism

Substances

  • ABO Blood-Group System
  • Anticoagulants
  • von Willebrand Factor
  • Vitamin K
  • Warfarin
  • F8 protein, human
  • Factor VIII